Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence

Human Molecular Genetics

Volumn 6, Issue 4, 1997, Pages 519-525

  Montgomery, Robert A ^a   Dietz, Harry C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; FIBRILLIN; RIBOZYME; SMALL NUCLEAR RNA;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; GENE REPRESSION; GENE TARGETING; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; PROKARYOTE; RNA STRUCTURE;

BASE SEQUENCE; BLOTTING, NORTHERN; CELL NUCLEUS; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, CATALYTIC; RNA, COMPLEMENTARY; RNA, MESSENGER; RNA, SMALL NUCLEAR; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

MAMMALIA; PROKARYOTA;

EID: 0030899989     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.4.519     Document Type: Article

References (32)

1. Neckers, L. and Whitesell, L. (1993) Antisense technology: biological utility and practical considerations. Am. J. Physiol. 265, LI-12.
2. Stein, C.A. (1995) Does antisense exist? Nature Med. 1, 1119-1121.
3. Izant, J.G. and Weintraub, H. (1984) Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 36, 1007-1015.
4. Wagner, E.G.H. and Simons, R.W. (1994) Antisense RNA controls in bacteria, phages, and plasmids. Annu. Rev. Microbiol. 48, 713-742.
5. Simons, R.W. (1988) Naturally occuring antisense RNA control - a brief review. Gene 72, 35-44.
6. Case, C.C. et al. (1989) The unusual stability of the IS410 anti-sense RNA is critical for its function and is determined by the structure of its stem-domain. EMBO J. 8, 4297-4305.
7. Hjalt, T.A. and Wagner, E.G. (1995) Bulged-out nucleotides protect an antisense RNA from RNase III cleavage. Nucleic Acids Res. 23, 571-579.
8. Hirashima, A., Sawaki, S., Inokuchi, Y. and Inouye, M. (1986) Engineering of the mRNA-interfering complementary RNA immune system against viral infection. Proc. Natl. Acad. Sci. USA 83, 7726-7730.
9. Zhong, L., Batt, D.B. and Carmichael, G.G. (1994) Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. Proc. Natl. Acad. Sci. USA 91, 4258-4262.
10. Guthrie, C. and Patterson, B. (1988) Spliceosomal snRNAs. Annu. Rev. Genet. 22, 387-419.
11. Hamm, J., Darzynkiewicz, E., Tahara, S.M. and Mattaj, W.I. (1990) The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear signal. Cell 62, 569-577.
12. Fischer, U. et al. (1991) Diversity in the signals required for nuclear accumulation of U snRNA and variety in the pathways of nuclear transport. J. Cell Biol. 113, 705-714.
13. Carmo-Fonseca, M. et al. (1991) Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machinery. EMBO J. 10, 195-206.
14. Dietz, H.C. et al. (1991) Marfan syndrome caused by a recurrent de novo missense in the fibrillin gene. Nature 352, 337-339.
15. Cech, T.R. and Bass, B. L. (1986) Biological catalysis by RNA. Anna. Rev. Biochem. 55, 599-629.
16. Haseloff, J. and Gerlach, W.L. (1988) Simple RNA enzyme with new and highly specific endoribonuclease activities. Nature 334, 585-591.
17. Sullenger, B.A and Cech, T.R. (1993) Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262, 1566-1569.
18. Michienzi, A., Prislei, S. and Bozzoni, I. (1996) U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immmunodeficiency virus. Proc. Natl. Acad. Sci. USA 93, 7219-7224.
19. Cornelissen, M. (1989) Nuclear and cytoplasmic sites for anti-sense control. Nucleic Acids Res. 17, 7203-7209.
20. Hendry, P., McCall, M.J., Santiago, F.S. and Jennings, P.A. (1992) A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability. Nucleic Acids Res. 20, 5737-5741.
21. Deshler, J.O., Li, H., Rossi, J.J. and Castanotto, D. (1995) Ribozymes expressed within the loop of a natural antisense RNA from functional transcription terminators. Gene 155, 35-43.
22. Bertrand, E., Pictet, R. and Grange, T. (1994) Can hammerhead ribozymes be efficient tools to inactivate gene function. Nucleic Acids Res. 22, 293-300.
23. De Young, M.B. et al. (1994) Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA. Biochemistry 33, 12127-12138.
24. Jones, M.H. and Guthrie, C. (1990) Unexpected flexibility in an evolutionarily conserved protein-RNA interaction: genetic analysis of the Sm binding site. EMBO J. 9, 2555-2561.
25. Boelens, W.C., Palacios, I. and Mattaj, I.W. (1995) Nuclear retention of RNA as a mechanism for localization. RNA 1, 273-283.
26. Dietz, H.C. and Pyeritz, R.E. (1995) Mutations in the human gene for fibrillin-1 (FBN1) in Marfan syndrome and related disorders. Hum. Mol. Genet. 4, 1799-1809.
27. Zhuang, Y. and Weiner, A.M. (1986) A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation Cell 46, 827-835.
28. Deng, W.P. and Nickoloff. J.A. (1992) Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200, 81-88.
29. Sakai, L.Y., Keene, D.R. and Engvall, E. (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol 103, 2499-2509.
30. Eldadah, Z.A. et al. (1995) Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a marfan cellular phenotype. J. Clin. Invest. 95, 874-880.
31. Lehrach, H., Diamond, D.,Wozney, J.M. and Boedtker, H. (1977) RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16, 4743-4751.
32. Feinberg, A.P. and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.